Landscapes / Companies

InventisBio Co., Ltd not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
2 in Phase 2
Next date
D-0502, Phase 3 trial completes
Drugs
5
in active trials · 7 in all
Trials
15 active
31 since 2021

Drugs5

DrugHow it worksPartnerStageNext dateDetails
—
Phase 3 30 Nov 2026soonPhase 3 trial completes
—
Phase 3 12 Jul 2027Phase 3 trial completes
—
Phase 1/2 31 Dec 2027Phase 1/2 trial completes
—
InxMed (Shanghai)
Phase 1/2 31 Dec 2027Phase 1/2 trial completes
—
Phase 1 30 Sep 2028Phase 1 trial completes

About

No active trial
Befotertinib, D-0120
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow InventisBio Co., Ltd

Following is part of Solo: you see every change to InventisBio Co., Ltd the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in